UK's Human Fertilisation & Embryology Act 2008 in force
This article was originally published in Clinica
The Human Fertilisation and Embryology Act 2008 came into force on October 1. The review of its predecessor, the Human Fertilisation and Embryology Act 1990, was conducted in large measure to reflect technological developments, and is "particularly important with regards to stem cell regulation and research", according to the UK's BioIndustry Association. The government described the legislation as "ensuring that the UK remains at the forefront of scientific advances in this field". The Act "ensures regulation of human-admixed embryos, created from a combination of human and animal genetic material for stem cell research".
You may also be interested in...
The first trial of the new Flash ultra-high dose radiation therapy with Varian Medical Systems’ ProBeam particle accelerator has begun. Agum Sharda, Varian’s senior director of Flash, says the technology could be a major advance for cancer patients.
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.